Increased CD103+ T lymphocytes in lymph nodes as a marker of metastasis from non-haematopoietic malignancies | Synapse
April 10, 2026
Increased CD103+ T lymphocytes in lymph nodes as a marker of metastasis from non-haematopoietic malignancies
Key Points
The research aims to identify the relationship between CD103+ T lymphocyte frequency and non-haematopoietic malignancies.
Analyzed excisional and core needle biopsies from lymph nodes
Assessed frequency of CD103+ T lymphocytes
Focused on cases of clinically concerning lymphadenopathy
Increased CD103+ T cells were significantly associated with metastatic non-haematopoietic malignancies
Frequency of CD103+ T cells can serve as a potential biomarker for metastasis
Abstract
Increased frequency of CD103+ T cells is associated with metastatic non-haematopoietic malignancies in excisional and core needle biopsies of clinically concerning lymphadenopathy.